Mumbai, Oct. 1 -- Securities in F&O Ban:

Shares of SAIL were banned from F&O trading on 1 October 2026.

Stocks to Watch:

Aurobindo pharmaceutical subsidiary, Acrotech Biopharma Inc., announced the US launch of ADQUEY (difamilast 1%) ointment, a non-steroidal topical treatment for mild-to-moderate atopic dermatitis in adults and pediatric patients aged two years and older. The launch marks Acrotech's entry into the US dermatology market. Difamilast was originally discovered by Otsuka Pharmaceutical and licensed to Acrotech Biopharma for commercialisation in the US.

NCC has received two additional orders in September, totalling Rs 500.22 crore. Of the two orders, Rs 224.74 crore pertains to the buildings division, while Rs 275.48 crore ...